Keyphrases
Pancreatic Ductal Adenocarcinoma
100%
Tumor
50%
Nanotherapeutics
50%
Nanoparticles
50%
Drug Nanoparticles
25%
Fibroblasts
25%
Antifibrotic
25%
Tumor Cells
25%
Matrix metalloproteinase-2 (MMP-2)
25%
Molecular Signature
12%
Integrin
12%
High Heterogeneity
12%
Fibrous Tissue
12%
Vascularization
12%
Drug Block
12%
Tumor Microenvironment
12%
Cleavable Linker
12%
Targeted Nanoparticles
12%
Tumor-associated Macrophages
12%
Synergistic Effect
12%
Double Function
12%
Conventional Chemotherapy
12%
Anticancer Drugs
12%
Nanoparticle Accumulation
12%
Human Pancreatic Ductal Adenocarcinoma
12%
Cytotoxic Drugs
12%
Effective Therapy
12%
Free Drug
12%
Simultaneous Action
12%
Biomolecular Signatures
12%
Hypoxia
12%
Aggressiveness
12%
Drug Penetration
12%
Targeted Nanocarriers
12%
Cancer Phenotype
12%
PLGA Copolymers
12%
Genetic Engineering
12%
Pancreatitis
12%
Biomolecular Pathways
12%
Cellular Signatures
12%
Molecular Characterization
12%
Tumor Stroma
12%
FDA-approved Drugs
12%
Tumor Region
12%
Magnetic Resonance Imaging
12%
Biocompatibility
12%
Drug Delivery
12%
Radiotherapy
12%
Medicine and Dentistry
Pancreas Adenocarcinoma
100%
Nanoparticle
88%
Neoplasm
66%
Stroma
33%
Malignant Neoplasm
22%
Gelatinase A
22%
Side Effect
22%
Fibroblast
22%
Tumor Cell
22%
Copolymer
11%
Nanocarrier
11%
Biological Marker
11%
Early Diagnosis
11%
Radiation Therapy
11%
Ex Vivo
11%
Drug Penetration
11%
Anticancer Drug
11%
Magnetic Resonance Imaging
11%
Cytotoxic Agent
11%
Vascularity
11%
Pancreatitis
11%
Cancer
11%
Macrophage
11%
Integrin
11%
Hypoxia
11%
Tumor Microenvironment
11%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Adenocarcinoma
100%
Nanoparticle
88%
Neoplasm
88%
Gelatinase A
22%
Malignant Neoplasm
22%
Side Effect
22%
Integrin
11%
Cytotoxic Agent
11%
Copolymer
11%
Pancreatitis
11%
Hypoxia
11%
Nanocarrier
11%
Chemotherapy
11%
Murine
11%
Tumor Microenvironment
11%
Anticancer Drug
11%
Biological Marker
11%